Researchers Lay Groundwork for Graphene-based Diagnostic Devices
|
By LabMedica International staff writers Posted on 18 Mar 2019 |

Image: Researchers combined graphene with nano-sized metal ribbons of gold to create an ultrasensitive biosensor that could help detect a variety of diseases in humans and animals (Photo courtesy of Oh Group, University of Minnesota).
A breakthrough in the use of graphene as a plasmon resonator for ultrasensitive infrared spectroscopy should enable development of new biosensors for detection of diseases at the molecular level.
Graphene is a form of carbon consisting of a single layer of carbon atoms arranged in a hexagonal lattice. It is a semimetal with small overlap between the valence and the conduction bands. As such, it can be considered as an indefinitely large aromatic molecule, the ultimate case of the family of flat polycyclic aromatic hydrocarbons. Graphene is the basic structural element of many other forms of carbon, such as graphite, charcoal, carbon nanotubes and fullerenes. Graphene has many uncommon properties such as being the strongest material ever tested while conducting heat and electricity efficiently and being nearly transparent.
Graphene's remarkable single atom thickness minimizes its efficiency to interact with light that is shined through it. Since light absorption and conversion to local electric fields is essential for detecting small amounts of molecules, this has prevented significant use of graphene as a basis for diagnostic devices.
Investigators at the University of Minnesota (Minneapolis/St. Paul, USA) have now combined graphene with nano-sized metal ribbons of gold. Using sticky tape and a high-tech nanofabrication technique called “template stripping,” they created an ultra-flat base layer surface for graphene that made the material suitable for use as an acoustic plasmon resonator.
Plasmon resonance is a phenomenon that occurs when light is reflected off thin metal films, which may be used to measure interaction of biomolecules on the surface. An electron charge density wave arises at the surface of the film when light is reflected at the film under specific conditions. A fraction of the light energy incident at a defined angle can interact with the delocalized electrons in the metal film (plasmon) thus reducing the reflected light intensity. The angle of incidence at which this occurs is influenced by the refractive index close to the backside of the metal film, to which target molecules are immobilized. If ligands in a mobile phase running along a flow cell bind to the surface molecules, the local refractive index changes in proportion to the mass being immobilized. This can be monitored in real time by detecting changes in the intensity of the reflected light.
The investigators reported that graphene-based acoustic plasmons allowed ultrasensitive measurements of absorption bands and surface phonon modes in ångström-thick protein and SiO2 layers, respectively. The acoustic plasmon resonator platform was scalable and could harness the ultimate level of light–matter interactions at nearly 94% efficiency for potential applications including spectroscopy, sensing, metasurfaces, and optoelectronics. When protein molecules were inserted between the graphene and metal ribbons, enough energy was harnessed to view single layers of protein molecules.
“In order to detect and treat many diseases we need to detect protein molecules at very small amounts and understand their structure,” said senior author Dr. Sang-Hyun Oh, professor of electrical and computer engineering at the University of Minnesota. “Currently, there are many technical challenges with that process. We hope that our device using graphene and a unique manufacturing process will provide the fundamental research that can help overcome those challenges. Our computer simulations showed that this novel approach would work, but we were still a little surprised when we achieved the 94% percent light absorption in real devices. Realizing an ideal from a computer simulation has so many challenges. Everything has to be so high quality and atomically flat. The fact that we could obtain such good agreement between theory and experiment was quite surprising and exciting.”
This work was detailed in the February 11, 2019, online edition of the journal Nature Nanotechnology.
Related Links:
University of Minnesota
Graphene is a form of carbon consisting of a single layer of carbon atoms arranged in a hexagonal lattice. It is a semimetal with small overlap between the valence and the conduction bands. As such, it can be considered as an indefinitely large aromatic molecule, the ultimate case of the family of flat polycyclic aromatic hydrocarbons. Graphene is the basic structural element of many other forms of carbon, such as graphite, charcoal, carbon nanotubes and fullerenes. Graphene has many uncommon properties such as being the strongest material ever tested while conducting heat and electricity efficiently and being nearly transparent.
Graphene's remarkable single atom thickness minimizes its efficiency to interact with light that is shined through it. Since light absorption and conversion to local electric fields is essential for detecting small amounts of molecules, this has prevented significant use of graphene as a basis for diagnostic devices.
Investigators at the University of Minnesota (Minneapolis/St. Paul, USA) have now combined graphene with nano-sized metal ribbons of gold. Using sticky tape and a high-tech nanofabrication technique called “template stripping,” they created an ultra-flat base layer surface for graphene that made the material suitable for use as an acoustic plasmon resonator.
Plasmon resonance is a phenomenon that occurs when light is reflected off thin metal films, which may be used to measure interaction of biomolecules on the surface. An electron charge density wave arises at the surface of the film when light is reflected at the film under specific conditions. A fraction of the light energy incident at a defined angle can interact with the delocalized electrons in the metal film (plasmon) thus reducing the reflected light intensity. The angle of incidence at which this occurs is influenced by the refractive index close to the backside of the metal film, to which target molecules are immobilized. If ligands in a mobile phase running along a flow cell bind to the surface molecules, the local refractive index changes in proportion to the mass being immobilized. This can be monitored in real time by detecting changes in the intensity of the reflected light.
The investigators reported that graphene-based acoustic plasmons allowed ultrasensitive measurements of absorption bands and surface phonon modes in ångström-thick protein and SiO2 layers, respectively. The acoustic plasmon resonator platform was scalable and could harness the ultimate level of light–matter interactions at nearly 94% efficiency for potential applications including spectroscopy, sensing, metasurfaces, and optoelectronics. When protein molecules were inserted between the graphene and metal ribbons, enough energy was harnessed to view single layers of protein molecules.
“In order to detect and treat many diseases we need to detect protein molecules at very small amounts and understand their structure,” said senior author Dr. Sang-Hyun Oh, professor of electrical and computer engineering at the University of Minnesota. “Currently, there are many technical challenges with that process. We hope that our device using graphene and a unique manufacturing process will provide the fundamental research that can help overcome those challenges. Our computer simulations showed that this novel approach would work, but we were still a little surprised when we achieved the 94% percent light absorption in real devices. Realizing an ideal from a computer simulation has so many challenges. Everything has to be so high quality and atomically flat. The fact that we could obtain such good agreement between theory and experiment was quite surprising and exciting.”
This work was detailed in the February 11, 2019, online edition of the journal Nature Nanotechnology.
Related Links:
University of Minnesota
Latest Molecular Diagnostics News
- Simple Urine Test to Revolutionize Bladder Cancer Diagnosis and Treatment
- Blood Test to Enable Earlier and Simpler Detection of Liver Fibrosis
- Genetic Marker to Help Children with T-Cell Leukemia Avoid Unnecessary Chemotherapy
- Four-Gene Blood Test Rules Out Bacterial Lung Infection
- New PCR Test Improves Diagnostic Accuracy of Bacterial Vaginosis and Candida Vaginitis
- New Serum Marker-Editing Strategy to Improve Diagnosis of Neurological Diseases
- World’s First Genetic Type 1 Diabetes Risk Test Enables Early Detection
- Blood Test to Help Low-Risk Gastric Cancer Patients Avoid Unnecessary Surgery
- First-Of-Its-Kind Automated System Speeds Myeloma Diagnosis
- Blood Protein Profiles Predict Mortality Risk for Earlier Medical Intervention
- First Of Its Kind Blood Test Detects Gastric Cancer in Asymptomatic Patients
- Portable Molecular Test Detects STIs at POC in 15 Minutes
- Benchtop Analyzer Runs Chemistries, Immunoassays and Hematology in Single Device
- POC Bordetella Test Delivers PCR-Accurate Results in 15 Minutes
- Pinprick Blood Test Could Detect Disease 10 Years Before Symptoms Appear
- Refined C-Reactive Protein Cutoffs Help Assess Sepsis Risk in Preterm Babies
Channels
Clinical Chemistry
view channel
Chemical Imaging Probe Could Track and Treat Prostate Cancer
Prostate cancer remains a leading cause of illness and death among men, with many patients eventually developing resistance to standard hormone-blocking therapies. These drugs often lose effectiveness... Read more
Mismatch Between Two Common Kidney Function Tests Indicates Serious Health Problems
Creatinine has long been the standard for measuring kidney filtration, while cystatin C — a protein produced by all human cells — has been recommended as a complementary marker because it is influenced... Read moreHematology
view channel
Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk
Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more
Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients
Assessing disease severity in sickle cell disease (SCD) remains challenging, especially when trying to predict hemolysis, vascular injury, and risk of complications such as vaso-occlusive crises.... Read more
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read moreImmunology
view channel
New Test Distinguishes Vaccine-Induced False Positives from Active HIV Infection
Since HIV was identified in 1983, more than 91 million people have contracted the virus, and over 44 million have died from related causes. Today, nearly 40 million individuals worldwide live with HIV-1,... Read more
Gene Signature Test Predicts Response to Key Breast Cancer Treatment
DK4/6 inhibitors paired with hormone therapy have become a cornerstone treatment for advanced HR+/HER2– breast cancer, slowing tumor growth by blocking key proteins that drive cell division.... Read more
Chip Captures Cancer Cells from Blood to Help Select Right Breast Cancer Treatment
Ductal carcinoma in situ (DCIS) accounts for about a quarter of all breast cancer cases and generally carries a good prognosis. This non-invasive form of the disease may or may not become life-threatening.... Read moreMicrobiology
view channel
Rapid Diagnostic Test Matches Gold Standard for Sepsis Detection
Sepsis kills 11 million people worldwide every year and generates massive healthcare costs. In the USA and Europe alone, sepsis accounts for USD 100 billion in annual hospitalization expenses.... Read moreRapid POC Tuberculosis Test Provides Results Within 15 Minutes
Tuberculosis remains one of the world’s deadliest infectious diseases, and reducing new cases depends on identifying individuals with latent infection before it progresses. Current diagnostic tools often... Read more
Rapid Assay Identifies Bloodstream Infection Pathogens Directly from Patient Samples
Bloodstream infections in sepsis progress quickly and demand rapid, precise diagnosis. Current blood-culture methods often take one to five days to identify the pathogen, leaving clinicians to treat blindly... Read morePathology
view channel
Tunable Cell-Sorting Device Holds Potential for Multiple Biomedical Applications
Isolating rare cancer cells from blood is essential for diagnosing metastasis and guiding treatment decisions, but remains technically challenging. Many existing techniques struggle to balance accuracy,... Read moreAI Tool Outperforms Doctors in Spotting Blood Cell Abnormalities
Diagnosing blood disorders depends on recognizing subtle abnormalities in cell size, shape, and structure, yet this process is slow, subjective, and requires years of expert training. Even specialists... Read moreTechnology
view channel
Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis
Identifying which genetic variants actually cause disease remains one of the biggest challenges in genomic medicine. Each person carries tens of thousands of DNA changes, yet only a few meaningfully alter... Read more
AI Saliva Sensor Enables Early Detection of Head and Neck Cancer
Early detection of head and neck cancer remains difficult because the disease produces few or no symptoms in its earliest stages, and lesions often lie deep within the head or neck, where biopsy or endoscopy... Read moreIndustry
view channel
Abbott Acquires Cancer-Screening Company Exact Sciences
Abbott (Abbott Park, IL, USA) has entered into a definitive agreement to acquire Exact Sciences (Madison, WI, USA), enabling it to enter and lead in fast-growing cancer diagnostics segments.... Read more








